• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRI™ Website
      • ISPRI Downselect™
      • ISPRI Quantify™
      • ISPRI Analyze™
      • ISPRI Evaluate™
      • ISPRI-HCP™
      • ISPRI Design™
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAX™
      • EpiCC™
      • Ancer®
      • PreVAX™
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
  • Contact Us
Bioinformatics tools for identifying class I-restricted epitopes

Bioinformatics tools for identifying class I-restricted epitopes

by Adam | Oct 22, 2016

Methods (Epitope Mapping Issue). Bill Kwok, editor, Methods 29 (2003) 289–298.
T Cell Epitope Identification for Bovine Vaccines: An Epitope Mapping Method for BoLA A-11

T Cell Epitope Identification for Bovine Vaccines: An Epitope Mapping Method for BoLA A-11

by Adam | Oct 22, 2016

International Journal for Parasitology (Thematic Issue on Vaccines, David Brake Editor, (Vol 33/5-6 pp 641-653). 2003.
Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection

Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection

by Adam | Oct 22, 2016

J Immunol. 2003 Jul 1; 171(1):307-16.
Mapping Cross-Clade HIV-1 Vaccine Epitopes Using a Bioinformatics Approach

Mapping Cross-Clade HIV-1 Vaccine Epitopes Using a Bioinformatics Approach

by Adam | Oct 22, 2016

Vaccine 21 (2003) 4486–4504. https://www.sciencedirect.com/science/journal/0264410X.

Recent Posts

  • Artificial Intelligence / Human Intelligence Workshop 2025
  • Thinking Out Loud: December 2024
  • EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
  • Supporting Health Equity: EpiVax Highlights Partnerships and New Research from Clínica Esperanza and GAIA Vaccine Foundation
  • Thinking Out Loud: November 2024

Recent Comments

No comments to show.

Join our newsletter

 Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot. 

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline